Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease.
Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...
Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.
In a world where respiratory issues are increasingly common, finding practical solutions can be daunting. Breathe Drops ...
A multicenter collaboration has identified a potential new treatment for an aggressive sarcoma arising in the nerves. The ...
In today's fast-paced world, respiratory health is often neglected, especially for those suffering from chronic conditions ...
The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...
A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...
In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...
Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex ...
If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before de ...